MariMed Statistics

Total Valuation

MariMed has a market cap or net worth of CAD 51.64 million. The enterprise value is 193.12 million.

Market Cap	51.64M
Enterprise Value	193.12M

Important Dates

The last earnings date was Monday, March 3, 2025.

Earnings Date	Mar 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+4.33%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	343.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.00, with an EV/FCF ratio of -25.94.

EV / Earnings	-11.03
EV / Sales	0.85
EV / EBITDA	8.00
EV / EBIT	34.78
EV / FCF	-25.94

Financial Position

The company has a current ratio of 1.10, with a Debt / Equity ratio of 1.12.

Current Ratio	1.10
Quick Ratio	0.34
Debt / Equity	1.12
Debt / EBITDA	5.27
Debt / FCF	-17.10
Interest Coverage	0.56

Financial Efficiency

Return on equity (ROE) is -14.45% and return on invested capital (ROIC) is 1.44%.

Return on Equity (ROE)	-14.45%
Return on Assets (ROA)	1.20%
Return on Invested Capital (ROIC)	1.44%
Return on Capital Employed (ROCE)	2.44%
Revenue Per Employee	293,650
Profits Per Employee	-22,612
Employee Count	832
Asset Turnover	0.78
Inventory Turnover	3.23

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.64% in the last 52 weeks. The beta is 2.70, so MariMed's price volatility has been higher than the market average.

Beta (5Y)	2.70
52-Week Price Change	-61.64%
50-Day Moving Average	0.17
200-Day Moving Average	0.21
Relative Strength Index (RSI)	38.16
Average Volume (20 Days)	91,082

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.15

Income Statement

In the last 12 months, MariMed had revenue of CAD 227.28 million and -17.50 million in losses. Loss per share was -0.05.

Revenue	227.28M
Gross Profit	90.46M
Operating Income	5.56M
Pretax Income	-5.71M
Net Income	-17.50M
EBITDA	21.18M
EBIT	5.56M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 10.48 million in cash and 127.29 million in debt, giving a net cash position of -116.81 million.

Cash & Cash Equivalents	10.48M
Total Debt	127.29M
Net Cash	-116.81M
Net Cash Per Share	n/a
Equity (Book Value)	113.49M
Book Value Per Share	0.23
Working Capital	6.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.76 million and capital expenditures -17.21 million, giving a free cash flow of -7.45 million.

Operating Cash Flow	9.76M
Capital Expenditures	-17.21M
Free Cash Flow	-7.45M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 39.80%, with operating and profit margins of 2.45% and -7.70%.

Gross Margin	39.80%
Operating Margin	2.45%
Pretax Margin	-2.51%
Profit Margin	-7.70%
EBITDA Margin	9.32%
EBIT Margin	2.45%
FCF Margin	n/a

Dividends & Yields

MariMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.33%
Shareholder Yield	-4.33%
Earnings Yield	-33.90%
FCF Yield	-14.42%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MariMed has an Altman Z-Score of 0.47. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.47
Piotroski F-Score	n/a